|
|
 |
KMG CHEMICALS REPORTS THIRD QUARTER RESULTS
Net
Income
Up
66% to $2.8 Million or $0.25 Per Diluted Share
HOUSTON, TX – June
4,
2009 – KMG Chemicals, Inc. (NASDAQ: KMGB), a global
provider of specialty chemicals in carefully focused
markets, today announced financial results for the third
quarter and nine months ended April 30, 2009.
Overview of Third Quarter and Year-to-Date Results
For
the third quarter, net sales were $45.9 million compared
to $50.3 million in the third quarter of 2008.
Operating income was up 40% to $5.4 million versus $3.9
million in the third quarter of last year. Net income
rose 66% to $2.8 million or $0.25 per diluted share,
compared to $1.7 million or $0.15 per diluted share
in the
third quarter of last year.
Year-to-date net sales rose 38% to $142.3 million
producing operating income of $11.5 million, and net
income of $5.3 million or $0.47
per
diluted share. In the same period in
fiscal
2008, net sales were $103.0 million resulting in
operating income of $9.5 million, and net income of $4.8
million or $0.43 per diluted share.
Mr.
Neal Butler, President and CEO of KMG, commented, “We
are very pleased with our third quarter and fiscal
year-to-date operating results, especially in light of
the global recession. Our substantially improved
profitability for the quarter was due to higher Wood
Preservative revenues combined with the successful
implementation of cost reduction initiatives, the
overall reduction in raw material costs, as well as the
elimination of transition and integration costs
associated with our Electronic Chemicals business
acquired on December 31, 2007.”
Of the
$45.9 million in third quarter 2009 net sales,
Electronic Chemicals contributed approximately $17.3
million, Wood Preservatives generated $25.1 million and
Animal Health contributed $3.5 million. In the third
quarter of fiscal 2008, Electronic Chemicals generated
$26.1 million, and Wood Preservatives and Animal Health
generated net sales of $20.2 million and $4.0 million,
respectively.
Through the first nine months of fiscal 2009, Electronic
Chemicals generated net sales of $65.1 million, Wood
Preservatives generated $70.1 million and Animal Health
generated net sales of $7.1 million. In the same period
of fiscal 2008, Electronic Chemicals (acquired effective
December 31, 2007) generated $34.7 million, and Wood
Preservatives and Animal Health generated net sales of
$59.9 million and $8.4 million, respectively.
Mr.
Butler went on to say, “The global recession had an
impact on our Electronic Chemicals business where sales
volumes declined along with the contraction of the
global semiconductor market. However, the most
significant market contraction was in Asia, and our
concentration of business is in the U.S., thus the
impact on us was somewhat less severe. This advantageous
market position, along with aggressive cost reductions
allowed us to maintain profitability in the US market
despite lower sales. However, the more severe
contraction in the European semiconductor market
resulted in an operating loss at our KMG Italia unit.
While there are early indications that we may have
passed the trough of the downturn in Electronic
Chemicals, it is too early to predict
a
turnaround with any certainty. We started to see some
improvement in the North America segment late in the
third quarter but we believe challenging market
conditions will continue in both our U.S. and European
segments at least through the fourth quarter.”
Mr.
Butler continued, “As we had forecast, our Wood
Preservatives business performed well in the third
quarter. Creosote sales increased 27% to $18.2 million.
Demand by railroads for crossties treated with creosote
has continued near the top of its
historical range. Although railroads generally react to
lessened rail traffic by slowing maintenance programs,
based on what we’ve seen in fiscal 2009 to date, we
continue to believe that sales will remain relatively
stable
for the remainder of the calendar year.
Penta sales were better than expected,
increasing 17% to $6.9 million compared to $5.9 million
in the prior year period.
Penta
is used to treat approximately half of the utility poles
in the United States.
The
increase in sales experienced in the third quarter was
primarily driven by higher sales volumes.”
“Animal Health sales in the third quarter were down
relative to 2008.
Livestock, dairy and poultry markets have been under
stress from the current economic conditions, and
distributors are reluctant to build inventory of animal
health products in advance of the selling season, which
historically has been during our third and fourth fiscal
quarters. We have taken certain costs out of the
business to maintain profitability in fiscal 2009 in
line with last year. Animal Health sales represent
approximately 6% of KMG’s total annual revenue.”
Mr.
Butler concluded, “We were extremely pleased with the
level of profitability we achieved in the third quarter.
The
cost cutting initiatives undertaken across the board
were appropriate for these uncertain times, produced the
desired bottom line result, and should position us for
further improvement when the economy recovers. Based
upon year-to-date sales and the strong bottom line
performance achieved in the third quarter, we are
confident that we will be able to achieve our fiscal
2009 financial goals which anticipate
improved earnings in fiscal 2009 over fiscal 2008 as
well as anticipated revenue growth for the year of
approximately 20%.”
Balance Sheet Discussion
John
V. Sobchak, CFO of KMG, commented, “Net working capital
at the close of the third quarter was $33.9 million,
down 14% from the previous quarter.
We
have worked diligently at reducing working capital
requirements, particularly in our Electronic Chemicals
business. Total debt on April 30th
was $57.7 million, which included $10 million borrowed
on our revolving credit facility. That is down from
$66.0 million of total debt at the close of the previous
quarter. As of May 31st,
we had
further reduced the outstanding balance
on our revolving credit facility to $5.0 million, having
repaid $12.0 million of the $17.0 million borrowed on
that facility as of the end of the second quarter. We
expect to repay the remaining $5 million borrowed on the
revolver before our July 31st
year end.”
“While
our credit agreement requires a debt to EBITDA ratio of
no more than 3.25 at the end of the third quarter, our
ratio was 2.80. Our debt to capitalization ratio was 47%
versus our allowed maximum of 60%. Our fixed charge
coverage ratio was 1.54 for the quarter versus a
required minimum of 1.50. While our fixed charge
coverage ratio in particular was tight for the third
quarter, we anticipate all of our ratios improving
significantly in the fourth quarter.”
Conference Call
Messrs. Butler and Sobchak will conduct a conference
call focusing on the financial results at 10:00 a.m. ET
today, Thursday, June 4, 2009. Interested parties may
participate in the call by dialing 866-861-6730. Please
call in 10 minutes before the call is scheduled to
begin, and ask for the KMGB call (conference (D
#97209160).
The
conference call will also be webcast live via the
Investor Relations section of KMG’s website at
www.kmgchemicals.com.
To listen to the live call please go to the website at
least 15 minutes early to register, download and install
any necessary audio software. If you are unable to
listen live, the conference call will be archived on the
website.
(See
accompanying tables)
KMG
Chemicals, Inc.
Consolidated Statements of Income
(In
thousands, except per share data)
(UNAUDITED)
|
|
|
Three Months Ended
April 30, |
|
Nine Months Ended
April 30, |
|
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
NET SALES
|
|
$ |
45,869 |
|
$ |
50,259 |
|
$ |
142,309 |
|
$ |
103,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF SALES
|
|
30,519 |
|
35,180 |
|
97,693 |
|
71,010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
15,350 |
|
15,079 |
|
44,616 |
|
32,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
SELLING, GENERAL AND
ADMINISTRATIVE
EXPENSES
|
|
9,910 |
|
11,205 |
|
33,144 |
|
22,572 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
5,440 |
|
3,874 |
|
11,472 |
|
9,452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE): |
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
1 |
|
16 |
|
7 |
|
435 |
|
|
Interest expense
|
|
(732) |
|
(1,010 |
) |
(2,396) |
|
(1,791 |
) |
|
Other, net
|
|
(15) |
|
(15 |
) |
(295) |
|
(44 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total other expense,
net |
|
(746) |
|
(1,009 |
) |
(2,684) |
|
(1,400 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
INCOME FROM CONTINUING OPERATIONS
BEFORE INCOME TAXES
|
|
4,694 |
|
2,865 |
|
8,788 |
|
8,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income
taxes |
|
(1,902) |
|
(1,051 |
) |
(3,473) |
|
(2,997 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
INCOME FROM CONTINUING
OPERATIONS |
|
2,792 |
|
1,814 |
|
5,315 |
|
5,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
DISCONTINUED OPERATIONS |
|
|
|
|
|
|
|
|
|
|
Loss from discontinued
operations, before income taxes
|
|
(15) |
|
(219 |
) |
(22) |
|
(402 |
) |
|
Income tax benefit
|
|
5 |
|
84 |
|
8 |
|
151 |
|
|
Loss from discontinued
operations |
|
(10) |
|
(135 |
) |
(14) |
|
(251 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
$ |
2,782 |
|
$ |
1,679 |
|
$ |
5,301 |
|
$ |
4,804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
EARNINGS PER SHARE: |
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations |
|
$ |
0.25 |
|
$ |
0.16 |
|
$ |
0.48 |
|
$ |
0.46 |
|
|
Loss from discontinued
operations |
|
— |
|
(0.01 |
) |
— |
|
(0.02 |
) |
|
Net income
|
|
$ |
0.25 |
|
$ |
0.15 |
|
$ |
0.48 |
|
$ |
0.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations |
|
$ |
0.25 |
|
$ |
0.16 |
|
$ |
0.47 |
|
$ |
0.45 |
|
|
Loss from discontinued
operations |
|
— |
|
(0.01 |
) |
— |
|
(0.02 |
) |
|
Net income
|
|
$ |
0.25 |
|
$ |
0.15 |
|
$ |
0.47 |
|
$ |
0.43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED AVERAGE SHARES
OUTSTANDING: |
|
|
|
|
|
|
|
|
|
|
Basic
|
|
11,090 |
|
10,990 |
|
11,080 |
|
10,968 |
|
|
Diluted
|
|
11,208 |
|
11,227 |
|
11,217 |
|
11,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DATA: |
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
expense |
|
1,316 |
|
1,876 |
|
4,704 |
|
4,043 |
|
KMG Chemicals, Inc
Balance Sheet Highlights
(In thousands)
(UNAUDITED)
|
|
April 30, |
|
July 31, |
|
|
2009 |
|
2008 |
|
|
|
|
|
|
Cash and cash equivalents |
$1,815 |
|
$ 2,605 |
|
|
|
|
|
|
Total assets |
146,773 |
|
155,798 |
|
|
|
|
|
|
Long-term debt including current
portion |
57,666 |
|
61,016 |
|
|
|
|
|
|
Shareholders’ equity |
64,926 |
|
63,687 |
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and
distributes specialty chemicals to carefully focused
markets. The Company grows by acquiring and optimizing
stable chemical product lines and businesses with
established production processes. Its current operations are
focused on the wood treatment, electronic, and agricultural
chemical markets. For more information, visit the Company's
web site at
www.kmgchemicals.com.
The information in this news release includes certain
forward-looking statements that are based upon assumptions
that in the future may prove not to have been accurate and
are subject to significant risks and uncertainties,
including statements as to the future performance of the
company. Although the company believes that the expectations
reflected in its forward-looking statements are reasonable,
it can give no assurance that such expectations or any of
its forward-looking statements will prove to be correct.
Factors that could cause results to differ include, but are
not limited to, successful performance of internal plans,
product development acceptance, the impact of competitive
services and pricing and general economic risks and
uncertainties.
Contacts
KMG Chemicals, Inc.
John V. Sobchak, 713-600-3814
Chief Financial Officer
JSobchak@kmgchemicals.com
www.kmgchemicals.com
or
Investor Relations Counsel:
The Equity Group Inc.
Melissa Dixon, 212-836-9613
MDixon@equityny.com
or
Linda Latman, 212-836-9609
LLatman@equityny.com
www.theequitygroup.com
|
|
Home |
Contact Us
|
|
|